Comparison of interferonα2β monotherapy with the combination of thymosinα1 and interferonα2β in the treatment of anti-HBe-positive chronic hepatitis B in Turkey.

Simple item page
dc.contributor.authorSaruc, M
dc.contributor.authorYuceyar, H
dc.contributor.authorKucukmetin, N
dc.contributor.authorDemir, MA
dc.contributor.authorKandiloglu, AR
dc.date.accessioned2024-07-18T11:40:10Z
dc.date.available2024-07-18T11:40:10Z
dc.identifier.issn0016-5085
dc.identifier.urihttp://akademikarsiv.cbu.edu.tr:4000/handle/123456789/2206
dc.language.isoEnglish
dc.publisherW B SAUNDERS CO
dc.titleComparison of interferonα2β monotherapy with the combination of thymosinα1 and interferonα2β in the treatment of anti-HBe-positive chronic hepatitis B in Turkey.
dc.typeMeeting Abstract

Files

Collections

Web of Science Koleksiyonu